Compare Guidewire Software Inc. Common Stock (GWRE) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guidewire Software Inc. Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? Guidewire Software Inc. Common Stock trades at $163.81 (market cap $13.52B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B). The key difference: Guidewire Software Inc. Common Stock is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Guidewire Software Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guidewire Software Inc. Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| GWRE | KYMR | |
|---|---|---|
Market Cap | $13.52B | $8.88B |
Volume | 897,708 | 1,028,790 |
Sector | Technology | Health |
52-Week High | $254.23 | $127.31 |
52-Week Low | $102.69 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.48B | $8.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guidewire Software Inc. Common Stock
Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.
Read more on GWRE →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
